Search Results - andrew+ewald

2 Results Sort By:
Autoantibodies as Anti-cancer Therapeutic Agents
TITLE: Autoantibodies as Anti-cancer Therapeutic AgentsCASE NUMBER: C13604UNMET NEED It has been speculated that autoimmunity and cancer were linked but the missing step was how to turn that concept into a robust method for identifying which specific auto antibodies would be generally effective. This problem was especially acute due...
Published: 9/26/2024   |   Inventor(s): Andrew Ewald, Veena Padmanaban, Antony Rosen, Livia Casciola-Rosen
Keywords(s): Antibodies, Biologics, Breast Cancer, Cancers, Disease Indication, Immunotherapy, Single, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology > Breast Cancer, Clinical and Disease Specializations > Women's Health, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Biologics, Technology Classifications > Therapeutic Modalities > Immunotherapies, Clinical and Disease Specializations > Oncology
Molecular Signatures of Invasive Cancer Subpopulations
C11851: Assay and molecular signature to identify invasive cancer cell population in tumorsNovelty: This invention is an assay for evaluating the metastatic potential of epithelial cancers, and a molecular signature linked to aggressive and invasive cancer subpopulations.Value Proposition: Inventors have developed an assay to enable stratification of...
Published: 9/26/2024   |   Inventor(s): Kevin Cheung, Andrew Ewald
Keywords(s): Assay, Basic Research Biomarker, Biomarker, Cancer Cells, Cancers, Cell Model, Clinical Diagnostics, Diagnostic Biomarker, Discovery/Research Tools, Disease Indication, In Vitro Diagnostics, In Vitro Research Tool, Mechanism-of-action Biomarker, Prognostic Biomarker, Risk Stratification, Therapeutic Matter, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology > Epithelial Cancer
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum